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Several recent discoveries of the hallmark features of programmed cell death (PCD) in Plasmodium falciparum have presented
the possibility of revealing novel targets for antimalarial therapy. Using a combination of cell-based assays, ﬂow cytometry and
ﬂuorescence microscopy, we detected features including mitochondrial dysregulation, activation of cysteine proteases and
in situ DNA fragmentation in parasites induced with chloroquine (CQ) and staurosporine (ST). The use of the pan-caspase
inhibitor, z-Val-Ala-Asp-fmk (zVAD), and the mitochondria outer membrane permeabilization (MOMP) inhibitor, 4-hydroxy-
tamoxifen, enabled the characterization of a novel CQ-induced pathway linking cysteine protease activation to downstream
mitochondrial dysregulation, ampliﬁed protease activity and DNA fragmentation. The PCD features were observed only at high
(lM) concentrations of CQ. The use of a new synthetic coumarin-labeled chloroquine (CM-CQ) showed that these features may
beassociatedwithconcentration-dependentdifferencesindruglocalization.Byfurtherusingcysteineproteaseinhibitorsz-Asp-
Glu-Val-Asp-fmk (zDEVD), z-Phe-Ala-fmk (zFA), z-Phe-Phe-fmk (zFF), z-Leu-Leu-Leu-fmk (zLLL), E64d and CA-074, we were able
to implicate clan CA cysteine proteases in CQ-mediated PCD. Finally, CQ induction of two CQ-resistant parasite strains, 7G8 and
K1,revealstheexistenceofPCDfeaturesintheseparasites,theextentofwhichwaslessthan3D7.Theuseofthechemoreversal
agent verapamil implicates the parasite digestive vacuole in mediating CQ-induced PCD.
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The most deadly of the four clinically relevant malaria
parasites, Plasmodium falciparum, continues to kill an
estimated one million people annually.
1 Although current
drugs can combat the disease, the increase in resistance to
these medicines makes it crucial for new leads to be
uncovered, such that new therapeutic initiatives will be one
step ahead of disease progression.
2 One pathway yet to be
thoroughly explored for antimalarial development is that of
programmed cell death (PCD).
Recent reports highlight the existence of PCD features in
unicellular organisms including Blastocystis, Leishmania,
trypanosomes, Saccharomyces cerevisiae and Trichomonas
vaginalis.
3 Indeed, accounts of PCD in P. falciparum
4 and
the rodent malaria parasite P. berghei
5 have been docu-
mented, as featured by the fragmentation of DNA and a
loss of mitochondria membrane potential. However, other
reports suggest that P. falciparum does not undergo
PCD.
6–7
Besides inconclusive cell death features in the malaria
pathogen, there is a lack of evidence for a clear pathway
linking such features. In addition, PCD pathway mediators
have yet to be identiﬁed. Some studies have made use of
caspase inhibitors or substrates to suggest the involvement of
clan CD cysteine protease mediators such as metacaspase-
orthologs
8 or caspase 3-like proteases.
9 These assays,
however, have been shown to be nonspeciﬁc and do not
reliably discriminate between the clan CA and CD cysteine
proteases.
10–11
Our study began by characterizing the PCD pathway of
P. falciparum. First, we conducted three cell-based assays
and detected mitochondrial dysregulation, cysteine protease
activation and DNA fragmentation in both CQ- and
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brane permeabilization (MOMP) inhibitor, 4-hydroxytamox-
ifen, and pan-caspase inhibitor, z-Val-Ala-Asp-fmk (zVAD),
wereusedtodeterminetheorderinwhichthesePCDfeatures
occurred.Interestingly,thesequenceofeventsinCQ-induced
parasites showed a striking resemblance to the classical
mammalian apoptotic pathway even in the absence of
classical apoptotic machinery. Third, owing to the cross-
reactive nature of ﬂuoromethylketone (fmk) inhibitors, clan
CA-speciﬁc protease inhibitors E64d and CA-074 were used
and showed that clan CA cysteine proteases are crucial
mediators in the CQ-induced PCD pathway. Clan CA
proteases, in particular the cathepsins and calpains, have
already been implicated in protozoan PCD.
12–15 As such, the
discovery of clan CA proteases as PCD mediators in
P. falciparum presents a clear new target of therapeutic
intervention for future antimalarial design. Finally, the exis-
tenceofCQ-inducedPCDwasshownindrug-resistantstrains
7G8 and K1, and the importance of CQ’s lysosomotropic
nature in triggering these features is discussed.
Results
Mitochondrial membrane potential assay. The
accumulation of JC-1 J-aggregates in uninduced cells
showed that about 90% of the parasites contained
functional mitochondrion with transmembrane potential
(Dcm) (Figure 1a and c). Confocal microscopy conﬁrmed
the speciﬁcity of the aggregated mitochondrial stain
(Figure 1b). Treatment with CQ or ST caused a signiﬁcant
decline in this proportion to approximately 69 and 75%,
respectively (Figure 1a).
Pretreatment of parasite culture with 4-hydroxy-tamoxifen
(4HT) inhibited CQ-induced MOMP almost entirely, returning
the proportion of JC1-positive cells to B90% (Figure 1a).
However, 4HT was unable to exert a similar protective effect
for ST-induced parasites, suggesting that ST-induced
decrease in JC-1 values was independent of MOMP.
Pan-caspase inhibitor, zVAD, was similarly able to rescue
CQ-induced cells from loss of Dcm but was unable to protect
cells from ST-induced JC-1 loss (Figure 1a). Almost 90% of
CQ-induced cells pretreated with zVAD were JC1-positive
compared with 77% of ST-induced cells. This suggests
that the activity of cysteine proteases is upstream of MOMP
in CQ-induced cells.
The use of 4HT and zVAD in combination did not rescue
ST-induced cells from JC-1 loss, whereas CQ-induced cells
were completely rescued (Figure 1a).
Cysteine protease activity. In parasitized erythrocytes,
high background staining within the erythrocyte (data not
shown) deemed it necessary for parasites to be enriched by
saponin-lysis of the host erythrocyte such that ﬂuorescence
of the parasite itself could be clearly recorded. In uninduced
parasites, a basal level of CaspaTag activity was detected in
10% of the cells (Figure 2a and c). This proportion increased
signiﬁcantly on CQ and ST induction to 34 and 32%,
respectively. The retention of CaspaTag in a greater
proportion of CQ- and ST-induced parasites suggested that
the pan-caspase stain was bound to cysteine proteases that
had been activated by the drug treatments.
PreincubationoftheparasiteculturewithzVADreducedthe
basal proportion of uninduced cells that are CaspaTag-
positive to 5% and suppressed CQ-induced CaspaTag
binding to below 10% (Figure 2a). Interestingly, zVAD did
not reduce the proportion of CaspaTag-positive cells after ST
treatment.
Even in the absence of CQ and ST, 4HT increased the
proportion of CaspaTag-positive cells slightly to 17%
(Figure 2a). Moreover, 4HT increased the proportion of
CaspaTag-positive cells in ST-treated cultures from 32 to
80%, suggesting synergism between 4HT and ST on the
parasite. This synergistic effect was not preventable by zVAD
treatment. Despite this inherent toxicity, 4HT reduced
CaspaTag binding in CQ-induced cells from 34 to 15%,
showing clearly that MOMP is essential for cysteine protease
activity in CQ-induced parasites.
In situ DNA fragmentation. As with the CaspaTag assay,
parasitized cultures treated with various conditions were
saponin-enriched just before TUNEL staining and gated in an
identical manner. There was an increase in the proportion of
TUNEL-positive cells from 10 to 27% and 56% in parasites
induced by CQ and ST, respectively, indicating that these
two drugs induced in situ DNA fragmentation in parasites
(Figure 3a and c).
Pretreatment of parasite cultures with 4HT alone resulted in
an increase in TUNEL-positive cells to 22.5% (Figure 3a).
Moreover, 4HT was ineffective in reducing the percentage of
TUNEL-positive cells in both CQ- and ST-treated cultures,
possibly owing to its inherent toxicity.
PretreatmentwithzVAD,however,signiﬁcantlyreducedthe
TUNEL-positive population in CQ-induced but not in
ST-induced cultures (Figure 3a). This suggested that zVAD
was able to effectively inhibit the pathway leading to in situ
DNA fragmentation in CQ-induced parasites but not in ST-
induced populations.
In double inhibition studies, the proportion of CQ-induced
TUNEL-positive cells decreased but the toxic effects of 4HT
were still observable in the non-induced cultures (Figure 3a).
ST-induced cultures remained highly TUNEL-positive even
when inhibitors were used in combination.
Figure1 JC-1stainingofinfectedRBCsshowslossofmitochondrialmembranepotential(Dcm)inPlasmodiumfalciparumparasitestreatedwithdrugs.(a)Theproportion
ofJC1-positiveparasitesarerepresentedinabarcharttoshowpopulationspretreatedwithvehiclecontrol,10mM4-hydroxytamoxifen(4HT)or50mMz-VAD-fmk(zVAD)and
subjected to 8-h treatment with vehicle control ,3 0mM chloroquine or 10mM of staurosporine . Data represent means±S.E. (AvB, AvC and BvF, Po0.001; BvE,
Po0.01; BvD, Po0.05; N¼4) In each experiment, the full set of treatment conditions were carried out concurrently with the same batch of cells. Percentages represent
ratios normalized to the healthy control population in each experiment. (b) Confocal microscopy of an uninfected erythrocyte and a trophozoite-infected erythrocyte (adjoining
panels) with JC-1 monomer (green) accumulation in the parasite cytoplasm and J-aggregate (red) in the rod-shaped mitochondria of the same cell. (c) Flow cytometry
histograms showing the gating of JC1(red)-positive and JC1(green)-positive populations, the ratio of which represents the JC1-positive population
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Cell Death and DiseaseAs CQ-induced parasites displayed clearer PCD induction
and inhibition in MOMP, cysteine protease activity and in situ
DNA fragmentation assays, we focused on the characteriza-
tion of the CQ-induced pathway and its mediators.
Time course experiments with CaspaTag and JC-1. Time
course experiments on CQ-induced parasites showed that a
signiﬁcant decrease in JC-1-positive cells occurred after
4h of drug administration in contrast to the increase
in CaspaTag-positive cells that was signiﬁcant only after 6h
(Figure 4). This suggests that mitochondrial dysregulation
is an early-onset feature of PCD, which precedes the
activation of cysteine proteases. As it was also shown that
zVAD is able to prevent MOMP, the activity of cysteine
proteases must be essential for the loss of Dcm to take place.
We therefore posit that a small increase in protease activity
leads to mitochondrial permeabilization, which then ampliﬁes
the protease cascade in a positive feedback loop.
Preparation and validation of ﬂuorescent-labeled
chloroquine. To determine the localization of chloroquine
(CQ), we synthesized a CQ analog conjugated to biologically
benign coumarin (CM) ﬂuorophore.
16 HPLC and NMR
analyses indicated that coumarin-labeled chloroquine
(CM-CQ) was synthesized with excellent purity of 98%
(Supplementary data, Figure S11–13). To ascertain the
biological efﬁcacy of CM-CQ, IC50 curves were measured
and the inhibitory efﬁciencies of the CQ compounds
determined (Supplementary data, Figure S1A). In addition,
the effect of varying CM-CQ concentrations on JC-1 assay
was also measured (Supplementary data, Figure S2). These
assays show that CM-CQ behaves similar to CQ in parasite
killing and inducing MOMP, but with about 10-fold less
efﬁcacy.
Dose-dependent effect of CQ. JC-1 and CaspaTag assays
were used to investigate PCD features at different
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Figure 2 CaspaTag stainingof saponin-enriched Plasmodiumfalciparumparasitesshows theactivation of cysteine proteasesafterincubationwith drugs.(a) Percentage
of CaspaTag-positive cells pretreated with vehicle control, 10mM 4-hydroxytamoxifen (4HT) or 50mM z-VAD-fmk (zVAD) and subjected to 8h treatment with vehicle
control ,3 0mM chloroquine or 10mM of staurosporine . In each experiment, the full set of treatment conditions were carried out concurrently with the same batch of
cells.Datarepresentmeans±S.E.(AvB,AvC,BvG,AvD,CvFandBvE,Po0.001;N¼3)(b)Fluorescentmicroscopyand(c)ﬂowcytometryhistogramsshowtheincreasein
proportion of CaspaTag-positive cells after chloroquine treatment, with and without 30min preincubation with zVAD or 4HT
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Cell Death and Diseaseconcentrations of CQ (Figure 5a). At low nanomolar
concentrations, there were basal levels of PCD features
but at micromolar concentrations of CQ, there was a large
increase in the proportion of cells displaying MOMP and
activation of cysteine proteases. Confocal microscopy
revealed a dose-dependent relocalization of labeled CQ
from the DV at nanomolar concentrations to the cytoplasm at
micromolar concentrations (Figure 5b and Supplementary
Data, Figure S3).
Necrosis control experiments. To exclude the possibility
that the CQ-induced PCD is an unregulated necrotic death,
parasitized cultures were subjected to sodium azide and
501C treatments in the presence or absence of zVAD
R3
100 101 102 103 104
FITC Log
100 101 102 103 104
FITC Log
100 101 102 103 104
FITC Log
100 101 102 103 104
FITC Log
100 101 102 103 104
FITC Log
0
250
500
750
1000
C
o
u
n
t
s
R3
0
250
500
750
1000
C
o
u
n
t
s
R3
0
250
500
750
1000
C
o
u
n
t
s
R3
0
250
500
750
1000
C
o
u
n
t
s
R3
0
250
500
750
1000
C
o
u
n
t
s
0
10
20
30
40
50
60
70
80
90
100
Veh 4HT zVAD 4HT+zVAD
P
e
r
c
e
n
t
a
g
e
 
o
f
 
T
U
N
E
L
 
P
o
s
i
t
i
v
e
P
a
r
a
s
i
t
e
s
 
(
%
)
ac
b NA 
CQ 
ST
NA 
10.32%
CQ 
32.63%
ST
51.73%
CQ + 4HT 
24.66%
CQ + zVAD 
11.69%
F
G A
B
C
D
E
10.0 µm 10.0 µm
10.0 µm
10.0 µm
10.0 µm
10.0 µm
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Cell Death and Disease(Figure S4–S6). Both treatments resulted in a different cell
death proﬁle from the CQ-induced pathway and zVAD was
unable to inhibit these features. Heat treatment altered JC-1
background staining of the erythrocytes and therefore data
were excluded.
Effect of different inhibitors on CaspaTag
binding. Owing to the well-documented nonspeciﬁc bind-
ing of zVAD to both clan CD and CA proteases
10–11,14,17
coupled with the absence of any caspase-orthologs in
Plasmodium,
18 the range of inhibitors was extended to
elucidate the preferred substrate speciﬁcity of the target
protease. Besides CA-074, all the tested inhibitors prevented
the increase of CaspaTag-positive cells in CQ-induced
samples (Figure 6a). Inhibition by clan CA-speciﬁc inhibitor
E64d showed that target proteases were clan CA cysteine
proteases. Inhibition by z-Phe-Ala-fmk (zFA), z-Phe-Phe-fmk
(zFF) and z-Leu-Leu-Leu-fmk (zLLL) showed that target
proteases lack the P1-aspartate speciﬁcity characteristic of
caspases, and suggests the involvement of clan CA
proteases such as cathepsins and calpain-like proteases in
the pathway. Cathepsin B-speciﬁc CA-074 was unable to
fully prevent CaspaTag binding, suggesting that cathepsin
B-like proteases are partly involved in mediating the pathway.
Hoechst staining of DNA content. To verify the
effectiveness of the extended panel of inhibitors, parasites
were assayed for a loss of DNA content 10h after CQ treat-
ment. Healthy ring-stage parasites were used to distinguish
the G1 population (Supplementary data, Figure S7A) and a
control experiment excluded the possibility that CQ compe-
ted with Hoechst DNA-binding (Supplementary data, Figure
S7C). Finally, ﬂow cytometry histograms and ﬂuorescence
microscopy images (Supplementary data, Figure S7B and D)
were compared to characterize parasite cultures that had
been subject to various experimental conditions.
CQ-treated parasites showed an increased proportion of
cells with sub-G1 DNA content from 10 to over 20%
(Figure 6b). The effect of different inhibitors corroborated
ﬁndings of the previous section, suggesting that clan CA
proteases are essential in mediators for DNA degradation in
CQ-induced PCD and that cathepsin B-like proteases act in
concert with other clan CA mediators to give rise to DNA
breakdown.
Intracellular calcium studies. In healthy parasites, calcium
indicator ﬂuo-4-AM localized to the digestive vacuole (DV) of
healthy parasites (Supplementary data, Figure S8).
However, CQ treatment resulted in a redistribution of
Ca
2þ to the cytoplasm in a dose-dependent manner
(Supplementary data, Figure S8 and S9). To explore the
possibility that MOMP is Ca
2þ-mediated, a cell-permeable
calcium chelator, BAPTA-AM, was used but this did not
signiﬁcantly reduce the proportion of CQ-induced parasites
undergoing MOMP (Supplementary data, Figure S10).
Inter-strain comparisons for JC1 and Hoechst loss. We
subsequently assayed for PCD features in CQ-resistant 7G8
and K1 strains (Figure 7). The IC50 values of CQ in 7G8 and
K1 parasites were determined to be 76 and 202nM,
respectively (Supplementary Data, Figure S1B and S1C).
Pretreatment with VP lowered the IC50 values of 7G8 and K1
to 61 and 120nM, respectively. Interestingly, 7G8 cultures
mirrored 3D7 and showed a signiﬁcant drop in the JC1-
positive population at concentrations of CQ exceeding 3mM
of CQ (Figure 7a). In comparison, the drop in JC1-positive K1
cells was markedly less at this same concentration, and it
was only at a higher concentration of the drug that there was
a signiﬁcant decrease in the proportion of JC1-positive cells.
However, pretreatment of K1 with 10mM of chemoreversal
agent VP resulted in a signiﬁcant decrease in JC1-positive
cells even at 3mM of CQ.
As with 3D7, both 7G8 and K1 showed a signiﬁcant
increase in the proportion of parasites with sub-G1 DNA
content after CQ treatment (Figure 7b). However, these
proportions were signiﬁcantly lower than those observed in
3D7. Although VP pretreatment was able to signiﬁcantly
increase the proportion of K1 parasites with sub-G1 DNA
content, this reversion was incomplete. It should be noted that
BD LSRII showed better resolution of Hoechst-positive
parasites from the uninfected RBC population, and conse-
quentlytheproportion ofcellsshowingDNAloss asmeasured
by this cytometer was slightly greater than that measured in
the previous set of experiments using DAKO cytomation.
Discussion
Our results show that both CQ and ST treatment gives rise
to features of PCD in Plasmodium including MOMP, the
activation of cysteine proteases and in situ DNA fragmenta-
tion. These ﬁndings corroborate growing evidence supporting
the existence of PCD hallmarks in parasites induced by a
variety of agents including drugs,
8,19 febrile temperatures,
19–20
exposure to bilirubin resulting in reactive oxygen species
increase
9 and binding of platelets to infected erythrocytes.
21
Observation of apoptotic features such as chromatin
condensation, DNA fragmentation, phosphatidylserine expo-
sure, apoptotic body formation and caspase activity have
been shown by Al-Olayan et al.
5 in the mosquito midgut stage
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Cell Death and Diseaseof P. berghei. However, this could not be reproduced by
Le Chat et al.
22 In apoptotic P. falciparum, as induced by
drugsandheat-shocktreatments,Nyakerigaetal.
6andTotino
et al.
7 were unable to detect MOMP, DNA fragmentation and
laddering, or chromatin cleavage. In contrast, Meslin et al.
8
and Kumar et al.
9 showed MOMP, DNA fragmentation,
chromatincondensationandDEVDaseactivityinotherstrains
of P. falciparum induced by similar stimuli. Still other authors
observed evidence of autophagy or secondary necrosis
including cytoplasmic vacuolation in drug-resistant strains
such as PSS1 or a swelling of the food vacuole in CSC-1.
7,19
These discrepancies may be due to differing drug concentra-
tions, parasite strains, developmental stages, inducers and
assaying methods, complicating the conclusions that can be
reliably discerned.
Another limitation of the existing studies has been the
absence of deﬁnitive evidence outlining any pathway of PCD.
As unicellular eukaryotes may display more than one PCD
pathway,
23 the focus of this study was primarily to delineate
the pathway induced by CQ.
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Cell Death and DiseaseSeveral established MOMP inhibitors were investigated
(data not shown) and 4HT was shown to inhibit MOMP
in CQ-induced cells without signiﬁcantly reducing the
proportion of healthy cells in the control group. Current
evidence suggests that 4HT inhibits Ca
2þ-induced MOMP in
ischemic myocardiocytes by binding to Ca
2þ-activated
K
þ channels of the mitochondria.
24–25 However, this is not
likely to be the mechanism of action in the parasite as
preincubation of parasites with the Ca
2þ chelator BAPTA-AM
did not prevent MOMP. In addition to 4HT, the effectiveness
of zVAD in inhibiting MOMP in CQ-induced cells points clearly
toward the activity of cysteine proteases being upstream
of MOMP.
Despite some toxicity, 4HT was also able to partially reduce
the major proportion of CaspaTag-positive cells in CQ-treated
cultures, suggesting that MOMP occurs upstream of the bulk
of cysteine protease activation in CQ-treated cells. This
conclusion was supported by time course experiments that
showed MOMP occurring in a signiﬁcant proportion of cells at
4h after CQ induction, whereas the increase in CaspaTag-
positive cells was only signiﬁcant after 6h.
Pretreatment with 4HT was unable to prevent CQ-induced
DNA fragmentation. Instead, 4HT toxicity made it difﬁcult to
interpret ﬁndings. In contrast, zVAD pretreatment clearly
reduced TUNEL staining in CQ-induced cells, placing the
activation of cysteine proteases upstream of in situ DNA
fragmentation.
The effectiveness of zVAD’s inhibition of cysteine pro-
teases, leading to a concomitant change in the proportion of
CQ-induced parasites showing MOMP, cysteine protease
activity and DNA fragmentation, is strongly indicative of a
regulatedpathway linkingthesePCDfeatures. In addition, the
effect of 4HT in reducing CaspaTag-positive cells and time
pointexperimentsprovidesfurtherinsightintotheCQ-induced
pathway outlined below (Diagram 1b). Our model of
CQ-induced PCD suggests that the activity of cysteine
proteases is necessary for the loss of mitochondrial mem-
brane potential. This preceding event is likely to be involved in
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Figure7 Drug-resistantparasitesshowingdifferentPCDphenotypeproﬁles.(a)
Cultures of chloroquine-sensitive 3D7 and chloroquine-resistant 7G8 and K1 show
different levels of JC1 loss at different concentrations of the drug. VPþK1 culture
consisted of K1 parasites preincubated with 10mM of verapamil (VP) for 30min
before chloroquine treatments. Data represent means±S.E. (AvB and AvC,
Po0.001; BvD and DvF, Po0.01; AvE, Po0.05; N¼3). (b) 3D7, 7G8 and K1
parasites showing different proportion of cells with sub-G1 DNA content as
measured by Hoechst staining. Data represent means±S.E. (AvB, AvC, BvD and
DvC, Po0.001; DvE, Po0.01; CvE, Po0.05; N¼3)
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Figure6 (a)CaspaTagstainingofchloroquine-inducedPlasmodiumfalciparum
parasites pretreated with inhibitors. Percentage of CaspaTag-positive cells
preincubated for 30min with the following: Vehicle control; 50mM zVAD.fmk,
zDEVD.fmk and CA-074; 5mM of zFA.fmk, zFF.fmk and zLLL.fmk; 12.5mMo f
E64d. Thereafter, cells were subjected to 8-h treatment with vehicle control ,
30mM chloroquine . Data represent means±S.E. (AvB, Po0.001; BvC,
Po0.01;AvC,P¼0.054;N¼3)(b)Hoechststainingofparasitesshowingsub-G1
DNA content. The proportion of cells with weak Hoechst staining was assayed for
10h after treatment with or without 30mM chloroquine. Cultures had been
pretreated for 30min with the following: Vehicle control; 50mM zVAD.fmk,
zDEVD.fmk and CA-074; 5mM of zFA.fmk, zFF.fmk and zLLL.fmk; 12.5mMo f
E64d.WeakHoechststainingwasindicativeofDNAdegradationcorrespondingtoa
loss of DNA content leading to the sub-G1 population. Data represent means
±S.E. (AvB and AvC, Po0.001; BvC, Po0.05; N¼3)
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Cell Death and Diseasethe ampliﬁcation of protease activity, which results in DNA
fragmentation. As experiments with 4HT were complicated by
its toxicity, we cannot exclude the possibility that this
ampliﬁcation of the cysteine proteases can occur indepen-
dently of mitochondrial permeabilization.
Our CQ-induced PCD model resembles the classical model
of receptor-mediated apoptosis, which was recently reviewed
by Degterev and Yuan.
23 Although caspase 8 is able to
directly activate executioner caspase 3 to initiate apoptosis,
this process is greatly ampliﬁed through the mitochondrial
route (Diagram 1a).
Although these models display overall similarities in the
assayed characteristics, the absence of caspase homologs
and classical mediators of apoptosis, such as Bid, Bax, AIF,
a Classical Apoptotic Pathway: 
c Proposed Plasmodium falciparum Programmed Cell Death Model: 
b Proposed PCD Model in 3D7 and CQ-resistant 7G8 and K1: 
Low levels of
Caspase- 8
MOMP DNA fragmentation Caspase-3 Fas-L: Fas
3D7+ CQ MOMP  Cys Protease(s)  Cys Protease(s)  DNA frag/loss 
7G8 + CQ MOMP  Cys Protease(s)  Cys Protease(s)  DNA frag/loss 
K1 + CQ MOMP Cys Protease(s) Cys Protease(s) DNA frag/loss
VP  VP
DV swelling,
partially
permeabilized
Clan CA cysteine
proteases leak
from DV
MOMP
Others? 
Massive release of
digestive enzymes
and Clan CA
proteases to cytosol
DNA degradation
and loss
zVAD
4HT
zVAD
Cyt c?
ROS?
High-dose CQ
localizes to DV
DV
permeabilized
PfCRT  VP
Diagram1 (a)Intheclassicalapoptoticpathwayofmammaliancells,Fas-ligandbindingtoitsreceptorresultsintheactivationoflowlevelsofcaspase8.Caspase8then
results in a series of events leading to MOMP and the release of proapoptotic factors. These factors form the apoptosome with caspase 9 and elicit a strong caspase 3
response, ultimately inducing DNA fragmentation. (b) In 3D7 P. falciparum parasites treated with chloroquine (CQ), similar cell death features are observed. Inhibitionstudies
withzVAD.fmk(zVAD)and4-hydroxytamoxifen(4HT)suggestthatCQtreatmentresultsintheactivationoflowlevelsofcysteineproteases,whichtriggersmitochondriaouter
membranepermeabilization(MOMP).Inturn,thisresultsinanincreaseintheamountofcysteineactivity,whichcausesDNAdegradation.Thisorderedsequenceofeventsis
characteristicofa programmed celldeathpathway.Thispathwayisalso likelyto existinCQ-resistant 7G8parasites.Althoughshowingsimilarproportionsof cellswith MOMP
as 3D7, 7G8 parasites have a lesser degree of DNA degradation, suggesting that there are differences in the later-stage events of the pathway. In CQ-resistant K1 parasites,
differences in both the degree of MOMP and DNA degradation suggest that the earlier stages of the pathway may differ from 3D7. The effectiveness of verapamil in reducing
thesedifferencesshowstheimportanceofCQlocalizationtothedigestivevacuole(DV)inthispathway.Takentogetherwiththeresultsofotherstudies,amoredetailedmodel
of PCD in P. falciparum is proposed. (c) Only at high doses of CQ does the drug accumulate in the DV to an extent that causes the DV to swell and become partially
permeabilized. Clan CA proteases that are abundant in the DV leak into the cytoplasm of the parasite, resulting in the dysregulation of the mitochondrion. This places further
stress on the DV leading to its rupture and a release of its contents (more clan CA proteases and other hydrolytic enzymes), which degrades the DNA and eventually the
parasite
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Cell Death and DiseaseApaf-1 andBcl-2 proteins, alludes to differentmediators being
involvedintheprocessofCQ-inducedPCDinP.falciparum.
26
InST-induced cells, the ineffectivenessofzVAD and 4HTin
reducing PCD features suggests that a different phenomenon
is being observed. The high concentrations of ST may have
resulted in unregulated necrosis that is unlikely to be
prevented by any number of inhibitors.
27
An apparent limitation of this study is the high concentra-
tions of CQ used. In an attempt to consolidate competing
ﬁndings by different studies using different drug concentra-
tions (35nM–100mM),
6–8,19 parasites in this study were
initially exposed to a range of drug concentrations (30,
300nM, 3 and 30mM) of CQ for 8h and observed for features
of PCD. To ensure that parasites were all still in a comparable
trophozoite stage of development, an incubation time
exceeding 10h was not considered. As a signiﬁcant loss of
Dcm and an increase in CaspaTag-positive cells were
observed only with 3 and 30mM of CQ treatment, the latter
dose was used. These parameters worked optimally with
our protocols and allowed the investigation of multiple
PCD phenotypes at a single time point. Moreover, effective
zVAD-mediated inhibition of PCD features even at such high
doses of CQ suggests that key modulators of a well-regulated
pathway are indeed being targeted.
Conclusions on studies using micromolar concentrations of
CQ must not be projected as the primary mechanism of CQ’s
antimalarial activity. At physiological nanomolar concentra-
tions, lysosomotropic CQ accumulates in the DV and
interferes with hemazoin formation.
28 However, our ﬁndings
showed the drug being present in the cytoplasm of the
parasite at micromolar concentrations where it could bind
nonselectively to unknown cytosolic PCD mediators. Alter-
natively, relocalization of the drug at a high dose could be due
to the excessive accumulation of the lysosomotropic drug in
the DV leading to its compromise, the acidiﬁcation of the
cytoplasm and the accumulation of protonated CQ inside the
entire parasite.
To exclude the possibility that the proposed CQ-induced
PCD pathway is an unregulated necrotic event, two necrosis
controls were included. Both sodium azide and heat treat-
ments resulted in distinctly different cell death proﬁles
compared with CQ-induced cultures. Moreover, it was clearly
shown that zVAD was unable to modulate the extent of cell
deathfeatures,stronglysuggestingthatthesenecrosiscontrols
were genuinely undergoing an unregulated and disordered cell
death. The ineffectiveness of zVAD in limiting necrotic cell
death has been previously shown
29–30 and contrasts with
the well-ordered ‘programmed’ pathway characterized in
CQ-induced cells where downstream features of cell death
can clearly be inhibited by 4HT and zVAD.
Although the concentration of the CQ used limits this
study’s usefulness in understanding the therapeutic mechan-
isms of CQ’s antimalarial activity, the objective of discovering
novel mediators of P. falciparum PCD is not undermined. As
further research characterizes what takes place in the
parasite at such a dose of CQ, novel compounds speciﬁcally
targeting the mediators of this PCD pathway may be optimally
designed for antimalarial use.
Unlike the mammalian model, the identities of participating
cysteine proteases in CQ-induced P. falciparum remains
unknown, given the conspicuous absence of classical
apoptotic mediators. Meslin et al.
8 have suggested that a
clan CD protease PfMCA1 (a metacaspase homolog) was
a likely mediator of cell death in P. falciparum. However,
Le Chat et al.
22 showed that P. berghei metacaspases did not
have a role in PCD.
There is growing evidence that caspase inhibitors with fmk
or aldehyde reactive groups (including CaspaTag) are not as
speciﬁc as once believed, but can efﬁciently inhibit non-
caspase cysteine proteases including metacaspases, cal-
pains and cathepsins.
10,14,17 This nonspeciﬁc nature of zVAD
binding in our study is conﬁrmed by the fact that other fmk
moiety-containing inhibitors with different amino-acid
sequences (z-Asp-Glu-Val-Asp-fmk (zDEVD), zFA, zFF and
zLLL) seemed equally effective in reducing CaspaTag
binding. Moreover, zFA, zFF and zLLL do not have the
aspartate residue at the P1 position that is essential for
classical caspase binding. Although the nonspeciﬁc nature of
zVAD binding has allowed us to characterize the aforemen-
tioned pathway, we cannot ascertain the identity of its target
protease on the basis of its binding to zVAD alone. Thus, clan
CA-speciﬁc inhibitors such as E64d and CA-074 were
included as well.
Despite being a broad-acting inhibitor of clan CA cysteine
proteases, E64d does not crossreact with clan CD pro-
teases.
17,31–33 As E64d was effective at inhibiting CaspaTag
binding and DNA loss in CQ-induced cells, we concluded that
clan CA proteases are essential mediators of CQ-induced
PCD. In addition, as CaspaTag binds both Clan CA and CD
proteases, and Clan CA-speciﬁc E64d completely prevented
the increase in CaspaTag-positive cells, this suggests that
clan CA mediators are likely to be the proteases accounting
for the cysteine protease activity being detected. The partial
inhibition of PCD features by speciﬁc cathepsin B inhibitor,
CA-074, shows that there may be multiple pathways involving
clan CA proteases. Nevertheless, it would be premature to
exclude the involvement of clan CD proteases such as
PfMCA1 as regulators or even key downstream mediators of
CQ-induced PCD.
Conventionally, Clan CD caspases mediate apoptosis.
However, recent work highlights the importance of clan CA
papain-like proteases such as calpains and cathepsins in
PCD regulation through truncation of Bid or activation of Bax,
leadingtoMOMP.
34–36EventhoughBidandBaxhomologsdo
not exist in the parasite, it is conceivable that one or more
parasite clan CA proteases may function likewise to cleave
a novel parasite-speciﬁc mediator of MOMP. Clan CA
proteases are well associated with parasites and include
cathepsins and falcipains from the C1 family and calpains
from the C2 family.
17 P. falciparum 3D7 possesses a
preprocathepsin C homolog, a calpain homolog, four falci-
pains, SERA (serine-repeat antigens) and other uncharacter-
ized C1 proteases.
18
Interestingly, a study by Gazarini et al.
37 showed that
micromolar quantities of CQ triggered calcium release from
acidic compartments of P. chabaudi. Moreover, Farias et al.
38
observed that calcium release was accompanied by a
detection of cysteine-protease activity in the cytoplasm of
P. chabaudi and P. falciparum. Although the authors suggest
calpain involvement, this is unlikely as putative calpain
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domain.
14 Our own studies on 3D7 also showed a relocaliza-
tion of Ca
2þ from the DV of the parasite to the cytoplasm.
However, the use of the calcium chelator, BAPTA-AM, did
not inhibit MOMP in CQ-induced parasites. However, the
role of Ca
2þ in limiting other features of CQ-induced PCD
has yet to be fully investigated and it is still possible that
in CQ-induced PCD, cysteine protease are activated in
aC a
2þ-dependent mechanism as these authors have
suggested.
This CQ-induced PCD pathway would only be of interest to
drug developers if its existence were also established in
CQ-resistant strains of P. falciparum. As such, drug-resistant
7G8 and K1 were also investigated for features of PCD. CQ
resistance was initially believed to arise from mutations in
the DV transmembrane protein CQ-resistance transporter
(PfCRT).
39 Two distinct sets of mutations were found, one
originating from South America and the other from Southeast
Asia and Africa. These mutations in PfCRT allow the efﬂux of
CQ from its primary site of action, the DV, thereby conferring
resistance to the drug. Interestingly, this resistance, originat-
ingfromtheAsia-Africamutations,wasshowntobereversible
by VP and similarly structured compounds.
40
Despite the differences between 7G8 and K1 in PfCRT
mutation sets, both strains showed a signiﬁcant proportion of
cells with JC1-1 loss and DNA degradation, suggesting that
PCD pathways exist even in these resistant strains. Interest-
ingly, 7G8 showed a similar extent of cells exhibiting MOMP
as 3D7 but a lower proportion of cells with sub-G1 content,
even at higher CQ concentrations. In comparison, K1 showed
aVP-reversiblereductionintheproportionofcellswithMOMP
and DNA degradation that was only detectable at higher CQ
levels. These ﬁndings show the importance of PfCRT and
CQ’s localization in the DV for PCD to occur (Diagram 1b). In
addition, the lesser extent of PCD features even at high CQ
concentrations suggests that these CQ-resistant strains may
have a reduced propensity to undergo PCD. This model for
drug resistance has also been established in cancer cells
where treatment pressure leads to a selection of clones with
altered apoptotic machinery or regulatory components.
41
Such cells are more likely to survive and may be cross-
resistanttoother drugsusingtheapoptotic pathway.Although
further work on ﬁeld isolates and other PCD inducers are
needed, the potential of ﬁnding a link between drug resistance
and resistance to cell death in P. falciparum would be very
illuminating.
In summary, our present study not only shows that CQ and
ST treatments give rise to characteristic features of PCD, but
also a linear pathway implicating mitochondrial dysregulation,
clan CA cysteine protease activity and DNA fragmentation
is evident after CQ-induction. Although no speciﬁc mediators
have been identiﬁed at this juncture, we have determined
clan CA proteases as key pathway modulators. In addition,
we have shown that PCD features exist in drug-resistant
7G8 and K1 parasites, and are suitable for therapeutic
exploits. Besides providing promising targets for therapeutic
drugs, breakthroughs in this area of PCD modulators should
also enable a greater understanding of drug resistance
and the physiological role of PCD pathways in unicellular
organisms.
Materials and methods
Parasite culture. A CQ-sensitive laboratory strain of P. falciparum, 3D7
(MRA-102,MR4,ATCC,Manassas,Va,USA),andCQ-resistantstrains7G8(MRA-
154, MR4, ATCC) and K1 (MRA-159, MR4, ATCC) were cultured continuously with
minor modiﬁcations to the method previously described.
42 Parasite cultures were
maintained in 75 or 125cm
2 ﬂasks using malaria culture media (MCM) consisting of
RPMI 1640supplementedwith0.5%(w/v)albumaxI(Invitrogen,Auckland,New Zealand),
0.005% (w/v) hypoxanthine, 0.03% (w/v) L-glutamate, 0.25% (w/v) gentamycin and 2.5%
human erythrocytes.Flasks were gassed with 3%CO2,4%O 2and 93%N2and incubated
at 371C in a dark incubator. Culture medium was replenished during subculturing
onalternatedays.ThinGiemsasmearsweremadetodetermineparasitemiabefore
subculture and at the start of each experiment. Sorbitol synchronization was carried
out weekly to select for ring-stage parasites.
43 Saponin enrichment was carried out
before staining with CaspaTag and TUNEL assay to liberate the parasites from
host erythrocytes.
44 Cultures of approximately 7–10% parasitemia were used,
with parasites being in the late-ring stage (22–26h post-invasion) during the
administration of inhibitor and drugs, unless otherwise stated.
Drug preparation and treatments. CQ diphosphate (Sigma-Aldrich,
Dorset, UK) was dissolved in PBS and ﬁlter-sterilized to obtain working solutions
of 300mM, and stored in the dark at 41C. A new batch of CQ working solution was
made before each experiment. Unless otherwise stated, parasitized erythrocytes
were incubated for 8 or 10h in 30mM of CQ and washed twice with MCM before
assaying for apoptotic features. Staurosporine (ST, Sigma-Aldrich) stock solution
(1mM) was prepared by dissolving the drug in ﬁltered dimethylsulfoxide (DMSO)
and stored at  201C. Working concentrations of ST at 100mM were prepared
before each experiment by diluting the stock solution with MCM. Infected
erythrocytes were treated for 8 or 10h with 10mM ST, and washed twice with MCM
before cell death assays. For necrosis controls, cultures were incubated with either
0.1% (w/v) of sodium azide for 8 or 10h, or heat treated at 501C for 1h, and then
incubated at 371C for 8 or 10h. Verapamil (VP, Sigma-Aldrich) was dissolved in
PBS with 0.5% acetic acid, to a working concentration of 1mM, and parasite
cultures were pretreated with 10mM of VP for 30min before adding CQ. Vehicle
controls consisted of equivalent amounts of DMSO or acetic acid.
Synthesis of CM-CQ. Under a standard synthetic procedure,
45 using ﬂame-
dried glass apparatus under nitrogen atmosphere, des(N-ethyl)-CQ (25.0mg,
0.09mmol), that is, N-(7-chloro-4-quinolinyl)-N0-ethyl-1,4-diaminobutane,
46 was
dissolved in anhydrous acetonitrile (5.0ml). Finely powdered and predried
potassium carbonate (24.8mg, 0.2mmol) was then added, followed by the
addition of an anhydrous acetonitrile solution (1.0ml) of the known CM
a-bromoester (44.2mg, 0.1mmol), that is, 2-bromo-N-(2-(2-(7-(dimethylamino)-2-
oxo-2H-chromen-4-yl)acetamido)ethyl)-acetamide.
16 The mixture was stirred for
13h at room temperature, then ﬁltered and the ﬁltrate evaporated to give a yellow
residue. The residue was then puriﬁed by ﬂash column chromatography (230–400
mesh silica gel) to give CM-CQ (45.0mg, 0.074mmol) in 82% yield.
NMR measurements of CM-CQ were recorded on a 300MHz (for
1H) and 500MHz
(for
13C) Bruker spectrometer (Fallanden, Switzerland) ﬁtted with a pulse-ﬁeld gradient
probe. The residual resonance of deuterated solvents was used as an internal reference.
1HNMR (300MHz,MeOD)d: 0.87 (t,J¼6.4Hz, 3H),1.52–1.57(m,2H),1.62–1.74
(m, 2H), 2.41 (t, J¼ 7.0Hz, 2H), 2.49 (q, J¼7.0Hz, 2H), 2.97 (bs, 8H), 3.21
(m, 2H), 3.38–3.40 (m, 4H), 3.63 (s, 2H), 5.98 (s, 1H), 6.34 (d, J¼2.3Hz, 1H), 6.43
(d, J¼5.8Hz, 1H), 6.55 (dd, J¼2.6Hz, 9.1Hz, 1H), 7.25 (dd, J¼2.0Hz, 8.8Hz,
1H),7.42 (d,J¼8.8Hz,1H), 7.71 (d,J¼2.0Hz,1H), 7.99 (d,J¼9.1Hz,1H), 8.29
(d, J¼5.8Hz, 1H).
13C NMR (125MHz, MeOD): d 12.1, 26.2, 27.1, 40.0, 40.1,
40.2, 44.0, 47.4, 50.0, 55.7, 58.7, 98.6, 99.6, 109.7, 110.3, 110.5, 118.7, 124.5,
125.8, 126.8, 127.3, 136.2, 149.4, 152.2, 152.7, 154.6, 157.1, 164.2, 171.5, 175.2.
Analytical HPLC and mass spectrometry of CM-CQ was carried out on a
Shimadzu LC-IT-TOF system (Kyoto, Japan) equipped with an autosampler, using
a reverse-phase Phenomenex Luna (Torrance, CA, USA) 5mm C18, 50 3.0mm
column. Solvent mixtures of 0.1% TFA/H2O (solvent-A) and 0.1% TFA/CH3CN
(solvent-B) were used as coeluents under a linear gradient of 1–100% of solvent B
(over 45min; ﬂow rate of 0.5ml/min). This gave a purity of CM-CQ of 98% with a
found m/z [Mþ1] of 607.277 (calculated for C32H39ClN6O4: 607.280).
Inhibitor preparation and treatments. Inhibitors were all purchased from
Sigma-Aldrich, dissolved in manufacturer’s recommended solvents to stock
concentrations and stored at  201C. Working solutions were obtained by diluting
the stock concentration with MCM just before administration.Parasitecultures were
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concentrations were as follows: 4HT, 20mM; zVAD, zDEVD and CA-074, 50mM;
zFA, zFF and zLLL, 5mM; E64d, 12.5mM; BAPTA-AM, 1–50mM. Lower
concentrations of zFA, zFF and zLLL were used because of their poor solubility.
Vehicle control consisted of equivalent amounts of DMSO and/or ethanol in
accordance with solvent amounts used in various inhibitor treatments.
Mitochondria transmembrane potential assay. Cell-permeable lipophilic
cation probe JC-1 (Molecular Probes, Eugene, OR, USA), also known as 5,50,6 , 6 0-
tetrachloro-1,10,3,30-tetraethyl-benzimidazolylcarbocyanine iodine, normally has green
ﬂuorescence (525nm) but aggregates at high transmembrane potential of functional
mitochondria to emit an orange-red ﬂuorescence (excitation maximum at 590nm).
47
A ﬁnal concentration of 6mM of JC-1 was added to 0.5ml of treated parasitized
erythrocytes and incubated at 371C in a dark humidiﬁed candle jar for 30min.
Cells were washed twice with PBS and resuspended to the original volume before
being analyzed by ﬂow cytometry. Percentage of JC1(Red)/JC1(Green) ratios were
obtained to determine the extent of mitochondrial dysregulation as per the
manufacturer’s recommendations.
Cysteine protease activity assay. CaspaTag pancaspase in situ assay kit,
sulforhodamine (Chemicon, Temecula, CA, USA), consists of a membrane-permeable
ﬂuoromethylketoneinhibitorofcaspasesconjugatedtosulforhodamine(SR-VAD-fmk).
Saponin enrichment was performed on 2ml of treated cells, washed twice with 2ml
PBS and resuspended in 300ml MCM. In accordance with the manufacturer’s
instructions, each vial of CaspaTag was dissolved in 50mlD M S Ot op r o d u c et h e
CaspaTag stock solution (150 ) and stored in the dark at  201C Before staining,
further dilutions were made using MCM till a working solution of 30  CaspaTag was
obtained. To each sample, 7ml of the freshly prepared CaspaTag reagent was added
and the culture incubated at 371C in the dark for 1h. Thereafter, two washes were
carried out with 1ml of the wash buffer provided. The samples were resuspended in
1ml of wash buffer before ﬂow cytometry analysis.
In situ DNA fragmentation assay. ApoDirect DNA Fragmentation Assay kit
(Clontech, San Diego, CA, USA) is a TUNEL (terminal deoxynucleotidyltransferase
dUTPnicked-endlabeling)assaythatmakesuseofFITC-conjugateddUTPincorporation
into nicked DNA by means of terminal deoxynucleotidyltransferase. Saponin enrichment
of 2ml of the treated cells also permeabilized the parasite’s plasma membrane to the
contentsoftheTUNELstain.Parasiteswerethenspundownandwashedtwicewith
1ml of wash buffer provided in the kit. Samples were then resuspended in 50mlo f
the premixed staining solution, as directed by the manufacturer, and incubated in
the dark for 90min at 371C. Samples were then washed twice in 1ml of rinse buffer
and resuspended in 1ml of PBS before ﬂow cytometry.
Hoechst staining of parasite DNA content. Hoechst 33342 stain
(provided together with CaspaTag kit, Chemicon) is a lipophilic DNA-binding
ﬂuorescent stain that is excited by ultraviolet light (350nm), and emits blue
ﬂuorescence light (461nm). After the parasite cultures were incubated in the
absence/presence of drugs/inhibitors for 10h, cells were washed twice with PBS
and 2ml of the 200mg/ml stain was added per 1ml of culture for 30min. The cells
were then washed twice and resuspended in PBS before ﬂow cytometry.
Intracellular calcium detection. Cell-permeable Fluo-4-AM (Molecular
Probes) ﬂuoresces green when bound with Ca
2þ and was used to detect
intracellular calcium stores. A ﬁnal concentration of 2mM of FLuo-4-AM was added
to 0.5ml of treated parasitized erythrocytes and incubated at 371C in a dark
humidiﬁed candle jar for 30min. Cells were washed twice with PBS and
resuspended to the original volume before viewing under a confocal microscope. At
least 30 parasitized cells were counted for each condition.
Inhibitory concentration (IC50) determination. Parasitized cultures
(ring stage) diluted with fresh erythrocytes and MCM to 2% parasitemia and
1.25% hematocrit were incubated with various concentrations of commercial
CQ (Sigma, Dorset, UK), CM (i.e., 7-dimethylamino-4-coumarinacetic acid) and
CM-CQ for 48h. To determine parasitemia, cultures were stained with Hoechst
33342, as described above, and analyzed by ﬂow cytometry.
Flow cytometric analyses. Cell numbers and ﬂuorescence intensity after
stainingwith JC-1, CaspaTag, FITC-dUTP or Hoechstwere assayedby aﬂow cytometer
(DAKO Cytomation Cyan ADP, Fort Collins, CO, USA), equippedwithanargon-ionlaser
tuned to 488nm and a violet laser tuned to 405nm. Blue, green and red ﬂuorescence
wasdetectedusing450,525and595nmband-passﬁlters,respectively.Forexperiments
involving 7G8 and K1, a high-throughput ﬂow cytometer (BD LSRII Special Order
System, San Jose, CA, USA) was used to manage the large number of samples
involved. Using BD LSR II, JC-1 stain was excited with 488nm blue laser with
green ﬂuorescence being detected using the 505LP 525/50BP ﬁlter, whereas red
ﬂuorescence was detected using the 570LP 585/42BP ﬁlter. For Hoechst stain,
excitation was by the 355nm UV laser, whereas detection used the 450LP 450/
50BP ﬁlter. Both ﬂow cytometers were adjusted for forward and side scattering to
accommodate either infected erythrocytes or liberated parasites. Between 100000
and 200000 erythrocytes or 10000–20000 enriched parasites were analyzed from
each sample and its respective duplicate to ensure reliability. At least three
independent experiments were performed unless otherwise stated.
Fluorescence and confocal microscopy. For ﬂuorescence microscopy,
wet mounts of stained infected erythrocytes or enriched parasites were observed
using an image analysis setup consisting of a light and ﬂuorescence microscope
(Olympus BX60, Japan) coupled to a microscope digital camera (Olympus DP71,
Tokyo, Japan) and images were captured using computer software DP Manager
version 3.1.1.208 (Olympus). Confocal imaging was performed using Olympus
Fluoview FV1000 (Japan) equipped with solid state and argon ion lasers tuned
to 405 and 488nm, respectively. Images were captured using Olympus Fluoview
version 1.6b. For enumeration purposes, images of at least 50 parasitized erythrocytes
were screened per concentration of drug used.
Statistical analyses. All data shown are means±S.E.M. Statistical
difference between percentages of stained cells was measured using univariate
t-test for means and comparisons between multiple groups were analyzed using
ANOVA and post hoc comparison using Tukey’s test for paired comparisons.
Signiﬁcantly different results (Po0.05) were highlighted.
Conﬂict of interest
The authors declare no conﬂict of interest.
Acknowledgements. We greatly appreciate the contributions of Jillian Cheong
during the early stages of this project, Cynthia He for help with confocal microscopy,
Georges Snounou and Laurent Renia for a critical reading of the manuscript, and
George Cross for critical input on experimental design. Research from Kevin Tan’s
laboratory has been generously supported by a grant from the Infectious Disease
Program, and Martin J. Lear gratefully acknowledges the Ministry of Education of
Singapore for funding (AcRF Tier-2 Grant T206B1112). The use of the ﬂow
cytometry facility of the Singapore MIT Alliance for Research and Technology
(SMART-ID IRG) is appreciated. C.J.H and S.R.K thank the National University of
Singapore for Graduate Scholarships. Also, we thank MR4 for providing us with
malaria parasites contributed by Daniel Carucci and Alister Craif (3D7) and Dennis
Kyle (7G8 and K1).
1. World Malaria Report 2008. World Health Organization: Geneva, Switzerland, 2008.
2. White NJ. The role of anti-malarial drugs in eliminating malaria. Malar J 2008;
7 (Suppl 1): S8.
3. Deponte M. Programmed cell death in protists. Biochim Biophys Acta 2008; 1783:
1396–1405.
4. HurdH,CarterV.TheroleofprogrammedcelldeathinPlasmodium-mosquitointeractions.
Int J Parasitol 2004; 34: 1459–1472.
5. Al-Olayan EM, Williams GT, Hurd H. Apoptosis in the malaria protozoan, Plasmodium
berghei: a possible mechanism for limiting intensity of infection in the mosquito. Int J
Parasitol 2002; 32: 1133–1143.
6. Nyakeriga AM, Perlmann H, Hagstedt M, Berzins K, Troye-Blomberg M, Zhivotovsky B
et al. Drug-induced death of the asexual blood stages of Plasmodium falciparum occurs
without typical signs of apoptosis. Microbes Infect 2006; 8: 1560–1568.
7. Totino PR, Daniel-Ribeiro CT, Corte-Real S, de Fatima Ferreira-da-Cruz M. Plasmodium
falciparum: erythrocytic stages die by autophagic-like cell death under drug pressure. Exp
Parasitol 2008; 118: 478–486.
8. Meslin B, Barnadas C, Boni V, Latour C, De Monbrison F, Kaiser K et al. Features of
apoptosis in Plasmodium falciparum erythrocytic stage through a putative role of PfMCA1
metacaspase-like protein. J Infect Dis 2007; 195: 1852–1859.
9. Kumar S, Guha M, Choubey V, Maity P, Srivastava K, Puri SK et al. Bilirubin inhibits
Plasmodium falciparum growth through the generation of reactive oxygen species. Free
Radic Biol Med 2008; 44: 602–613.
PCD of P. falciparum mediated by clan CA cysteine proteases
J-H Ch’ng et al
12
Cell Death and Disease10. Rozman-Pungercar J, Kopitar-Jerala N, Bogyo M, Turk D, Vasiljeva O, Stefe I et al.
Inhibition of papain-like cysteine proteases and legumain by caspase-speciﬁc inhibitors: when
reaction mechanism is more important than speciﬁcity. Cell Death Differ 2003; 10: 881–888.
11. Chauvier D, Ankri S, Charriaut-Marlangue C, Casimir R, Jacotot E. Broad-spectrum
caspase inhibitors: from myth to reality? Cell Death Differ 2007; 14: 387–391.
12. Stoka V, Turk B, Schendel SL, Kim TH, Cirman T, Snipas SJ et al. Lysosomal protease
pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route. J Biol
Chem 2001; 276: 3149–3157.
13. Madeo F, Herker E, Maldener C, Wissing S, Lachelt S, Herlan M et al. A caspase-related
protease regulates apoptosis in yeast. Mol Cell 2002; 9: 911–917.
14. Hurd H, Grant KM, Arambage SC. Apoptosis-like death as a feature of malaria infection in
mosquitoes. Parasitology 2006; 132 (Suppl): S33–S47.
15. Turk B, Stoka V, Rozman-Pungercar J, Cirman T, Droga-Mazovec G, Oresic K et al.
Apoptotic pathways: involvement of lysosomal proteases. Biol Chem 2002; 383: 1035–1044.
16. Alexander MD, Burkart MD, Leonard MS, Portonovo P, Liang B, Ding XB et al. A central
strategy for converting natural products into ﬂuorescent probes. Chembiochem 2006; 7:
409–416.
17. Mottram JC, Helms MJ, Coombs GH, Sajid M. Clan CD cysteine peptidases of parasitic
protozoa. Trends Parasitol 2003; 19: 182–187.
18. Wu Y, Wang X, Liu X, Wang Y. Data-mining approaches reveal hidden families of
proteases in the genome of malaria parasite. Genome Res 2003; 13: 601–616.
19. Porter H, Gamette MJ, Cortes-Hernandez DG, Jensen JB. Asexual blood stages of
Plasmodium falciparum exhibit signs of secondary necrosis, but not classical apoptosis
after exposure to febrile temperature (40 C). J Parasitol 2008; 94: 473–480.
20. Oakley MS, Kumar S, Anantharaman V, Zheng H, Mahajan B, Haynes JD et al. Molecular
factors and biochemical pathways induced by febrile temperature in intraerythrocytic
Plasmodium falciparum parasites. Infect Immun 2007; 75: 2012–2025.
21. McMorran BJ, Marshall VM, de Graaf C, Drysdale KE, Shabbar M, Smyth GK et al.
Platelets kill intraerythrocytic malarial parasites and mediate survival to infection. Science
2009; 323: 797–800.
22. Le Chat L, Sinden RE, Dessens JT. The role of metacaspase 1 in Plasmodium berghei
development and apoptosis. Mol Biochem Parasitol 2007; 153: 41–47.
23. Degterev A, Yuan J. Expansion and evolution of cell death programmes. Nat Rev Mol Cell
Biol 2008; 9: 378–390.
24. Morkuniene R, Jekabsone A, Borutaite V. Estrogens prevent calcium-induced release of
cytochrome c from heart mitochondria. FEBS Lett 2002; 521: 53–56.
25. OhyaS,KuwataY,SakamotoK,MurakiK,ImaizumiY.Cardioprotectiveeffectsofestradiol
include the activation of large-conductance Ca(2+)-activated K(+) channels in cardiac
mitochondria. Am J Physiol Heart Circ Physiol 2005; 289: H1635–H1642.
26. Deponte M, Becker K. Plasmodium falciparum – do killers commit suicide? Trends
Parasitol 2004; 20: 165–169.
27. Studzinski DM, Benjamins JA. Cyclic AMP differentiation of the oligodendroglial cell line
N20.1 switches staurosporine-induced cell death from necrosis to apoptosis. J Neurosci
Res 2001; 66: 691–697.
28. GoldbergDE, SlaterAF,Cerami A, Henderson GB. Hemoglobin degradationin themalaria
parasite Plasmodium falciparum: anordered process inauniqueorganelle.ProcNatl Acad
Sci USA 1990; 87: 2931–2935.
29. Kim SO, Han J. Pan-caspase inhibitor zVAD enhances cell death in RAW246.7
macrophages. J Endotoxin Res 2001; 7: 292–296.
30. Sperandio S, de Belle I, Bredesen DE. An alternative, nonapoptotic form of programmed
cell death. Proc Natl Acad Sci USA 2000; 97: 14376–14381.
31. Tamai M, Yokoo C, Murata M, Oguma K, Sota K, Sato E et al. Efﬁcient synthetic method for
ethyl (+)-(2S,3S)-3-[(S)-3-methyl-1-(3-methylbutylcarbamoyl)butylcarbamoyl]-2-oxiranecarb
oxylate (EST), a new inhibitor of cysteine proteinases. Chem Pharm Bull (Tokyo) 1987; 35:
1098–1104.
32. McGowan EB, Becker E, Detwiler TC. Inhibition of calpain in intact platelets by the thiol
protease inhibitor E-64d. Biochem Biophys Res Commun 1989; 158: 432–435.
33. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M et al.
Identiﬁcation and inhibition of the ICE/CED-3 protease necessary for mammalian
apoptosis. Nature 1995; 376: 37–43.
34. Broker LE, Kruyt FA, Giaccone G. Cell death independent of caspases: a review. Clin
Cancer Res 2005; 11: 3155–3162.
35. Bursch W. The autophagosomal-lysosomal compartment in programmed cell death. Cell
Death Differ 2001; 8: 569–581.
36. Borner C, Monney L. Apoptosis without caspases: an inefﬁcient molecular guillotine? Cell
Death Differ 1999; 6: 497–507.
37. GazariniML,SigoloCA,MarkusRP,ThomasAP,GarciaCR.Antimalarialdrugsdisruption
homeostasis in malarial parasites. Mem Inst Oswaldo Cruz 2007; 102: 329–334.
38. Farias SL, Gazarini ML, Melo RL, Hirata IY, Juliano MA, Juliano L et al. Cysteine-protease
activity elicited by Ca2+ stimulus in Plasmodium. Mol Biochem Parasitol 2005; 141: 71–79.
39. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT et al. Mutations in
the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their
role in chloroquine resistance. Mol Cell 2000; 6: 861–871.
40. Yeh S, Smith PJ, Chibale K. Dual-acting diamine antiplasmodial and chloroquine
resistance modulating agents. Biochem Pharmacol 2006; 72: 156–165.
41. Pommier Y, Sordet O, Antony S, Hayward RL, Kohn KW. Apoptosis defects and
chemotherapy resistance: molecular interaction maps and networks. Oncogene 2004; 23:
2934–2949.
42. Trager W, Jensen JB. Human malaria parasites in continuous culture. 1976. J Parasitol
2005; 91: 484–486.
43. LambrosC,VanderbergJP.SynchronizationofPlasmodiumfalciparumerythrocyticstages
in culture. J Parasitol 1979; 65: 418–420.
44. Beaumelle BD, Vial HJ, Philippot JR. Reevaluation, using marker enzymes, of the ability of
saponin and ammonium chloride to free Plasmodium from infected erythrocytes.
J Parasitol 1987; 73: 743–748.
45. Prusov E, Maier ME. Synthesis of nitrogen-containing spirocyclic scaffolds via
aminoallylation/RCM sequence. Tetrahedron 2007; 63: 10486–10496.
46. Natarajan JK, Alumasa JN, Yearick K, Ekoue-Kovi KA, Casabianca LB, de Dios AC et al.
4-N-, 4-S-, and 4-O-chloroquine analogues: inﬂuence of side chain length and
quinolyl nitrogen pKa on activity vs chloroquine resistant malaria. J Med Chem 2008;
51: 3466–3479.
47. Smiley ST, Reers M, Mottola-Hartshorn C, Lin M, Chen A, Smith TW et al. Intracellular
heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming
lipophilic cation JC-1. Proc Natl Acad Sci USA 1991; 88: 3671–3675.
Cell Death and Disease is an open-access journal
published by Nature Publishing Group. This article is
licensed under a Creative Commons Attribution-Noncommercial-No
DerivativeWorks3.0License.Toviewacopyofthislicense,visithttp://
creativecommons.org/licenses/by-nc-nd/3.0/
Supplementary Information accompanies the paper on Cell Death and Disease website (http://www.nature.com/cddis)
PCD of P. falciparum mediated by clan CA cysteine proteases
J-H Ch’ng et al
13
Cell Death and Disease